Generic weight loss drugs boosted by UK approval for Biocon
The Bengaluru-based firm, that has been churning out off-patient medicines treating diabetes, scored an early win with the UK approval for the first generic version of liraglutide injectable, whose patent ends in November.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
UK risks critical medicine shortage as EU lures drugmakers
For subscribers